The molecule, called STING, triggers the buildup of plaques and tangles that are hallmarks of Alzheimer's. Alzheimer’s patients have an accumulation of amyloid plaques outside neurons and an ...

Blocking STING appears to slow both plaque buildup and tangle formation – the two main hallmarks of Alzheimer’s. In contrast, other molecules play a more limited role and can be targeted only at ...

The test works by measuring proteins beta-amyloid and p-tau217, which are believed to be hallmarks of Alzheimer’s disease. Alzheimer's is a degenerative brain disease that is caused by complex ...

Its mouthful of a name — Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio — describes what the test measures: levels of two proteins, amyloid and tau, that are hallmarks of Alzheimer’s disease.

A ratio of those proteins tends to correlate with the occurrence or absence of amyloid plaques in the brain, which are among the hallmarks of Alzheimer’s disease. The test does not measure ...